t9p logo transpng

TN-T2

Overview

TN-T2 is a synthetic peptide in the same class as TN-R3, designed to act on two of the receptors the body uses to manage blood sugar and appetite: the GLP-1 and GIP receptors. Both respond to hormones the gut releases after eating, a group known as incretins. This two receptor pairing was the design that opened the current generation of metabolic research, and it remains one of the most extensively studied combinations in the field. Engaging both incretin receptors together, rather than the GLP-1 receptor alone, is the central idea behind it.

How it works

When food is digested, the intestine releases the incretins GLP-1 and GIP, which prompt insulin release in step with blood sugar. TN-T2 is built to activate both of their receptors together, and both belong to the same family of cell surface receptors that signal through a shared internal messenger called cyclic AMP. In study models the two receptors influence one another’s signaling, so combining them is examined as more than the sum of two separate effects. Researchers study how that interaction plays out once the signals reach the inside of the cell.

What researchers study

The GLP-1 receptor is studied for steadying blood sugar, slowing stomach emptying, and reducing appetite through the brain. The GIP receptor is studied for insulin release and for how fat tissue stores energy. Much of the research compares activating both receptors against the GLP-1 receptor alone, measuring how the pair affects blood sugar, appetite, and energy use in study models. Because the two pathways act on each other directly, the combined signal is treated as a research question in its own right. As with related designs, much of the evidence still sits in animal and early stage models.

Published references

Research Use Only. Not for human or animal use.

View Certificate of Analysis
Shop Now
Scroll to Top